Literature DB >> 8905017

Spatial and temporal pattern of smooth muscle cell differentiation during development of the vascular system in the mouse embryo.

Y Takahashi1, T Imanaka, T Takano.   

Abstract

The initial phase of smooth muscle differentiation in the vascular system of the mouse embryo was observed immunohistochemically with monoclonal antibody against alpha-smooth muscle actin. Few smooth muscle cells were detected in the vascular system of the 9.5-day embryo, where only the dorsal aorta and umbilical artery showed signs of smooth muscle differentiation. In the 10.5-day embryo, smooth muscle cells were observed in the dorsal aorta, ventral aorta, omphalomesenteric artery and vein, umbilical artery and vein, internal carotid artery, aortic arches III and IV, and subclavian artery. The extent of smooth muscle differentiation varied among these vessels and among regions of a vessel. At 11.5 days of gestation, smooth muscle cells appeared in the basilar artery, vertebral artery, aortic arches VI, intersomitic artery, ductus venosus, and caudal artery. Smooth muscle cells were absent from the venous system characteristic of the embryo at the stages examined. Alpha-smooth muscle actin-positive cells were also observed in allantoic mesoderm in the placenta at 9.5 days, when the umbilical vessels were not surrounded by smooth muscle cells. Vascular smooth muscle cells appear to arise independently from mesenchyme at multiple sites in the vascular system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905017     DOI: 10.1007/bf00185997

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  21 in total

1.  Electron microscope study of developing chick embryo aorta.

Authors:  H E KARRER
Journal:  J Ultrastruct Res       Date:  1960-12

Review 2.  Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations.

Authors:  A P Sappino; W Schürch; G Gabbiani
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

3.  Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms.

Authors:  M Kuro-o; R Nagai; H Tsuchimochi; H Katoh; Y Yazaki; A Ohkubo; F Takaku
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

4.  Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles.

Authors:  J Woodcock-Mitchell; J J Mitchell; R B Low; M Kieny; P Sengel; L Rubbia; O Skalli; B Jackson; G Gabbiani
Journal:  Differentiation       Date:  1988-12       Impact factor: 3.880

5.  Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin.

Authors:  G Gabbiani; E Schmid; S Winter; C Chaponnier; C de Ckhastonay; J Vandekerckhove; K Weber; W W Franke
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  Retroviral analysis of cardiac morphogenesis: discontinuous formation of coronary vessels.

Authors:  T Mikawa; D A Fischman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Developing elastic tissue. An electron microscopic study.

Authors:  E N Albert
Journal:  Am J Pathol       Date:  1972-10       Impact factor: 4.307

8.  Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis.

Authors:  J M Miano; P Cserjesi; K L Ligon; M Periasamy; E N Olson
Journal:  Circ Res       Date:  1994-11       Impact factor: 17.367

9.  Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos.

Authors:  J D Coffin; T J Poole
Journal:  Development       Date:  1988-04       Impact factor: 6.868

10.  Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the alpha-vascular but not the gamma-enteric isoform in differentiating striated myocytes.

Authors:  N M Sawtell; J L Lessard
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  7 in total

1.  mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures.

Authors:  Stefan J Scheidl; Sven Nilsson; Mattias Kalén; Mats Hellström; Minoru Takemoto; Joakim Håkansson; Per Lindahl
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 2.  Development and pathologies of the arterial wall.

Authors:  Sara B Seidelmann; Janet K Lighthouse; Daniel M Greif
Journal:  Cell Mol Life Sci       Date:  2013-09-27       Impact factor: 9.261

3.  A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development.

Authors:  Takamune Takahashi; Keiko Takahashi; Patricia L St John; Paul A Fleming; Takuya Tomemori; Toshio Watanabe; Dale R Abrahamson; Christopher J Drake; Takuji Shirasawa; Thomas O Daniel
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

5.  Transitions in cell organization and in expression of contractile and extracellular matrix proteins during development of chicken aortic smooth muscle: evidence for a complex spatial and temporal differentiation program.

Authors:  Z Yablonka-Reuveni; B Christ; J M Benson
Journal:  Anat Embryol (Berl)       Date:  1998-06

6.  Intracellular localization of Cthrc1 characterizes differentiated smooth muscle.

Authors:  Renée J Leclair; Qiaozeng Wang; Meredith A Benson; Igor Prudovsky; Volkhard Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-08       Impact factor: 8.311

7.  SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis.

Authors:  Qingwei Zhu; Yong Hwan Kim; Douglas Wang; S Paul Oh; Kunxin Luo
Journal:  J Cell Biol       Date:  2013-09-09       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.